Reaction
Suspected Product Quality Issue reporting signals
As of the last recalculation, Suspected Product Quality Issue appears in 1,748 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 12.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 33 | 12.8 | 12.8 |
| Pegvaliase-Pqpz | 8 | 11.6 | 11.7 |
| Botulinum Toxin Type A | 12 | 11.6 | 11.6 |
| Progesterone | 19 | 10.0 | 10.0 |
| Liothyronine Sodium | 7 | 9.6 | 9.6 |
| Propofol | 27 | 8.9 | 8.9 |
| Estradiol Gel 0.1% | 30 | 8.0 | 8.0 |
| Estradiol Transdermal | 30 | 8.0 | 8.0 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 26 | 7.6 | 7.6 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 21 | 7.2 | 7.2 |
| Lisdexamfetamine Dimesylate | 19 | 6.9 | 6.9 |
| Patiromer | 7 | 6.0 | 6.0 |
| Onabotulinumtoxina | 36 | 5.6 | 5.7 |
| Etonogestrel | 12 | 3.0 | 3.0 |
| Docosanol | 3 | 2.4 | 2.4 |